ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
ZBIO
65 hedge funds and large institutions have $260M invested in Zenas BioPharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+22
Holders Change %
+51.16%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
13
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$8.24M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
$8.02M |
3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$13.1M |
4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
$5.14M |
5 |
Geode Capital Management
Boston,
Massachusetts
|
$2.86M |